Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

For full access to this article login to GEN Select now.

May 01, 2014 (Vol. 34, No. 9)

Arecor Employs Excipients for Biologics Stability

Reformulations Significantly Improve Stability of Proteins and Peptides

  • When biologics took center stage in the pharmaceutical development pipeline, Thomas Reese Saylor, president and CEO of Arecor, realized that developers needed new approaches to drug formulation. As he tells GEN, “When pharmaceutical pipelines were dominated by small molecules, formulation was considered only when drugs were in the later ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.